Study on Accelerated Radiation Therapy for Early-Stage Breast Cancer

Sponsor: Weill Medical College of Cornell University

Sponsor score: 40
Inactive

ClinicalTrials ID:NCT04175210

Provider View

This clinical trial is comparing two different schedules of radiation therapy for women with early-stage breast cancer. The study aims to determine if a shorter course of treatment is as effective as the standard longer course.

Patient Parameters

Program Overview

The purpose of this study is to compare two different radiation therapy schedules for women with early-stage breast cancer. Participants will be randomly assigned to receive either the standard radiation therapy over 15 sessions or an experimental shorter course over 10 sessions. The study will help determine if the shorter treatment is as effective as the standard approach in treating breast cancer.

Eligibility Criteria

Inclusion Criteria

  • Women who have had a segmental mastectomy (breast-conserving surgery).
  • Have early-stage breast cancer (Stage T1-T2) that has been completely removed with clear margins.
  • If cancer is in both breasts, it must be early-stage and completely removed with clear margins.
  • No cancer found in lymph nodes.
  • Ductal carcinoma in situ (DCIS) that has been completely removed with clear margins.

Exclusion Criteria

  • Have had previous radiation therapy to the same breast.
  • More than 90 days since the last surgery, unless chemotherapy was given after surgery.
  • More than 60 days since the last chemotherapy session.
  • Male breast cancer patients are not eligible.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.